Livingstone Health’s strategy rooted in patient care and steady growth
The Catalist-listed group is prioritising quality over rapid expansion
[SINGAPORE] Livingstone Health is not in a rush to grow.
Much like the lithops – a hardy succulent also known as a living stone, from which the company takes its name – the Singapore-based healthcare group is taking a slow and steady approach to expansion.
The Catalist-listed company, which went public in 2021, operates 20 clinics in the Republic, staffed by 22 medical specialists and practitioners. It also runs a health-screening centre, two medical aesthetics clinics, a podiatry clinic, and provides healthcare consultancy services within the region.
TRENDING NOW
Singapore households’ net wealth up, but also taking on more debt such as home loans
With new S$10 million HQ, Jumbo Group looks to Shanghai-focused China strategy, premium dining for growth
Up to 11 new condo projects with 3,550 units lined up for H2 launch as price ceilings emerge
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned